BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19225296)

  • 1. The role of statins in chronic heart failure.
    Sadek MM; Haddad T; Haddad H
    Curr Opin Cardiol; 2009 Mar; 24(2):167-71. PubMed ID: 19225296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical outcome trials of statins in heart failure.
    Fonarow GC
    Heart Fail Clin; 2008 Apr; 4(2):225-9. PubMed ID: 18433703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of statins in heart failure.
    Gullestad L; Oie E; Ueland T; Yndestad A; Aukrust P
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():35-40. PubMed ID: 18001320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk.
    Laufs U; Custodis F; Böhm M
    Drugs; 2006; 66(2):145-54. PubMed ID: 16451090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use in heart failure: a cause for concern?
    Raina A; Pickering T; Shimbo D
    Am Heart J; 2006 Jul; 152(1):39-49. PubMed ID: 16824830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [To treat or not to treat with statins patients with chronic heart failure?].
    Hradec J
    Vnitr Lek; 2009 Sep; 55(9):802-7. PubMed ID: 19785380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of mortality in 6975 patients with chronic heart failure in the Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico-Heart Failure trial: proposal for a nomogram.
    Barlera S; Tavazzi L; Franzosi MG; Marchioli R; Raimondi E; Masson S; Urso R; Lucci D; Nicolosi GL; Maggioni AP; Tognoni G;
    Circ Heart Fail; 2013 Jan; 6(1):31-9. PubMed ID: 23152490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and heart failure.
    Filippatos TD; Mikhailidis DP
    Angiology; 2008; 59(2 Suppl):58S-61S. PubMed ID: 18508847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial.
    Røysland R; Masson S; Omland T; Milani V; Bjerre M; Flyvbjerg A; Di Tano G; Misuraca G; Maggioni AP; Tognoni G; Tavazzi L; Latini R;
    Am Heart J; 2010 Aug; 160(2):286-93. PubMed ID: 20691834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure.
    Lipinski MJ; Cauthen CA; Biondi-Zoccai GG; Abbate A; Vrtovec B; Khan BV; Vetrovec GW
    Am J Cardiol; 2009 Dec; 104(12):1708-16. PubMed ID: 19962481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and clinical outcomes in heart failure.
    Martin JH; Krum H
    Clin Sci (Lond); 2007 Aug; 113(3):119-27. PubMed ID: 17600528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic effects of statins in heart failure.
    Sandesara CM; Roodneshin H; Sbaity S; Olshansky B
    Heart Fail Clin; 2008 Apr; 4(2):187-200. PubMed ID: 18433699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cholesterol paradox in heart failure.
    Velavan P; Huan Loh P; Clark A; Cleland JG
    Congest Heart Fail; 2007; 13(6):336-41. PubMed ID: 18046092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence.
    Marchioli R; Silletta MG; Levantesi G; Pioggiarella R; Tognoni G
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):110-30. PubMed ID: 20196975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observational studies of statins in systolic heart failure.
    Levy WC
    Heart Fail Clin; 2008 Apr; 4(2):201-8. PubMed ID: 18433700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
    Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ; ;
    Circulation; 2015 Apr; 131(17):1486-94; discussion 1494. PubMed ID: 25810334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.
    Marchioli R; Levantesi G; Silletta MG; Barlera S; Bernardinangeli M; Carbonieri E; Cosmi F; Franzosi MG; Latini R; Lucci D; Maggioni AP; Moretti L; Nicolosi GL; Porcu M; Rossi MG; Tognoni G; Tavazzi L;
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):735-48. PubMed ID: 19589110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational studies of statins in heart failure with preserved systolic function.
    Fukuta H; Little WC
    Heart Fail Clin; 2008 Apr; 4(2):209-16. PubMed ID: 18433701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins in heart failure.
    Deedwania PC; Javed U
    Cardiol Clin; 2008 Nov; 26(4):573-87. PubMed ID: 18929232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.".
    Abdul-Rahim AH; Perez AC; Fulton RL; Jhund PS; Latini R; Tognoni G; Wikstrand J; Kjekshus J; Lip GY; Maggioni AP; Tavazzi L; Lees KR; McMurray JJ
    Circulation; 2015 Dec; 132(22):e358. PubMed ID: 26621661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.